| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director +2 more
45 companies
Ra Capital Management, L.P. is a Director, 10% Owner at WVE with holdings across 45 companies. Recent SEC Form 4 filings include 22 buys and 6 sells.
Estimated insider holdings value: $4519.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 45,768 | $9.96 | $455,725.68 | +0.1% | - | - | |
| Jul 24, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 41,319 | $9.99 | $412,776.81 | +0.2% | - | - | |
| Jul 23, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 264,586 | $9.76 | $2,583,314.22 | +0.5% | - | - | |
| Jul 22, 2026 | PBLS Parabilis Medicines, Inc. Common Stock | Director, 10% Owner | Buy | 244,593 | $28.29 | $6,919,551.27 | +0.2% | - | - | |
| Jul 17, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 160,354 | $8.93 | $1,432,118.86 | +0.5% | - | - | |
| Jul 13, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 6,522 | $8.94 | $58,306.68 | - | - | - | |
| Jul 13, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 21,654 | $8.96 | $194,039.82 | - | - | - | |
| Jun 16, 2026 | COAG Hemab Therapeutics Holdings, Inc. Common Stock | 10% Owner | Buy | 67,669 | $24.97 | $1,689,818.48 | +0.5% | - | - | |
| Jun 11, 2026 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 678,226 | $0.37 | $253,568.65 | -3.9% | - | - | |
| Jun 11, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 1,027,722 | $7.44 | $7,650,148.29 | +2.2% | - | - |